TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.

Andere talen Tonghua Dongbao Pharmaceutical Co., Ltd.

Aandelen

600867

CNE000000H87

slotkoers Shanghai S.E. Andere beurzen 00:00:00 27-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
8,44 ^CNY	-2,31%		-3,32%	-22,07%

21/06	Dongbao Pharmaceutical doneert eerste patiënt in diabetesmedicijntest	MT
15/05	Tonghua Dongbao Pharmaceutical start fase 1 studie voor diabetesinjectie in China	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Dongbao Pharmaceutical Doses First Patient in Diabetes Drug Trial	21/06
Tonghua Dongbao Pharmaceutical Launches Phase 1 Trial for Diabetes Injection in China	15/05
Dongbao Pharmaceutical's Deputy General Manager to Reduce Stake	10/05
JHM Biopharmaceutical Co., Ltd. announced that it has received CNY 100 million in funding from Tonghua Dongbao Pharmaceutical Co., Ltd.	08/05
JHM Biopharmaceutical Co., Ltd. announced that it expects to receive CNY 100 million in funding from Tonghua Dongbao Pharmaceutical Co., Ltd.	07/05
Dongbao Pharmaceutical's Profit, Operating Income Slip in Q1 2024	29/04
Tonghua Dongbao Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Dongbao Pharma's 2023 Profit Drops 26%	29/03
Tonghua Dongbao Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29/01
Dongbao Pharma Unit's Gout Drug Clinical Study Achieves Primary Endpoint	17/01
Dongbao Pharmaceutical's Unit Gets Nod to Trial Diabetes Drug	27/12
Dongbao Pharmaceutical Unit Gets Nod to Trial Diabetes Drug	12/12
Tonghua Dongbao Pharma Unit Enrolls First Subject for Clinical Trial of Diabetes Drug	06/12
Tonghua Dongbao Pharma Registers Diabetes Drug	05/12
Tonghua Dongbao Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30-10-23
Tonghua Dongbao Pharmaceutical's Insulin Injection Shows Positive Results in German Trial	24-10-23
Adocia : en nette hausse après des résultats positifs contre le diabète	23-10-23
Adocia Announces its Partner Tonghua Dongbao Releases Positive Results on the Three Clinical Studies Conducted on BioChaperone Combo THDB0207 Formulation Containing Insulin Glargine and Insulin Lispro from Tonghua Dongbao	23-10-23
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Announces an Exclusive Licensing Agreement with Tonghua Dongbao Pharmaceutical Co., Ltd. to Commercialize Three Insulin Biosimilars - Insulin Aspart, Insulin Lispro, and Insulin Glargine in the U.S	21-09-23
Tonghua Dongbao Pharmaceutical Co., Ltd.(XSSC:600867) added to S&P Global BMI Index	18-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Tonghua Dongbao Pharmaceutical Co., Ltd.

Aandelen

600867

CNE000000H87

Andere talen

Filters